^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

IL13 (Interleukin 13)

i
Other names: IL13, Interleukin 13, IL-13, P600, Interleukin-13, MGC116786, MGC116788, MGC116789, ALRH, BHR1, Bronchial Hyperresponsiveness-1 (Bronchial Asthma), Allergic Rhinitis, NC30
1d
Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients (clinicaltrials.gov)
P=N/A, N=52, Recruiting, Fondazione del Piemonte per l'Oncologia
New trial
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • CCL22 (C-C Motif Chemokine Ligand 22) • IL13 (Interleukin 13) • IL15 (Interleukin 15) • IL4 (Interleukin 4) • IL5 (Interleukin 5)
3d
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients (clinicaltrials.gov)
P=N/A, N=110, Recruiting, Fondazione del Piemonte per l'Oncologia
New trial
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • CCL22 (C-C Motif Chemokine Ligand 22) • IL13 (Interleukin 13) • IL15 (Interleukin 15) • IL4 (Interleukin 4) • IL5 (Interleukin 5)
7d
Pleione bulbocodioides Polysaccharides Reprogram Tumor-Associated Macrophages via JAK2/STAT3 Inhibition to Suppress Hepatocellular Carcinoma. (PubMed, J Hepatocell Carcinoma)
PBPs suppress HCC progression in association with modulation of TAM polarization and inhibition of JAK2/STAT3 signaling. These findings provide mechanistic insight into the immunomodulatory actions of PBPs and support their further investigation as macrophage-targeting agents for HCC.
Journal
|
JAK2 (Janus kinase 2) • IL10 (Interleukin 10) • IL13 (Interleukin 13) • IL4 (Interleukin 4)
12d
Neuroprotective Effects of Molecular Hydrogen via Oxidative Stress and Neuroinflammation Regulation in a 5xFAD Mouse Model. (PubMed, Antioxidants (Basel))
In the hippocampus, H2 upregulated nuclear factor erythroid 2-related factor 2 (NRF2), attenuated nuclear factor kappa B (NF-κB) activation, reduced the BAX/BCL-2 ratio, preserved neuronal nuclei (NEUN) expression, and decreased hippocampal Aβ42 burden. Collectively, these findings indicate that H2 inhalation confers multi-faceted neuroprotection in 5xFAD mice by restoring redox homeostasis, suppressing inflammation, improving mitochondrial function, and limiting Aβ accumulation.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • BAX (BCL2-associated X protein) • APP (Amyloid Beta Precursor Protein) • IL13 (Interleukin 13) • CAT (Catalase)
12d
Proteomic profiling and pathway analyses reveal molecular signatures and immune networks in pediatric sepsis. (PubMed, Inflamm Res)
Pediatric sepsis is characterized by dysregulation of multiple immune and inflammatory pathways rather than isolated protein abnormalities. IL-10 and related cytokine signaling emerged as central nodes, providing insights into the balance between hyperinflammation and immunosuppression in critically ill children. Associations between pathways and clinical variables suggest that specific pathogen types and infection sources trigger distinct patterns of biological network activation, offering potential targets for patient stratification and pathway-directed therapeutics.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • IL13 (Interleukin 13) • IL4 (Interleukin 4) • TNFSF14 (TNF Superfamily Member 14)
15d
Impact of rifampicin on P-glycoprotein (ABCB1) expression in M1 and M2 macrophages derived from the THP-1 monocytic cell line or peripheral blood mononuclear cells. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
In conclusion, ABCB1 expression in macrophages differs by the cell model (THP-1 cell line vs. primary PBMC) and the polarization phenotype (M1 vs. M2). Strong rifampicin-mediated enhancements of ABCB1 were only observed in THP-1-derived M1 and M2 cells.
Preclinical • Journal
|
IFNG (Interferon, gamma) • ABCB1 (ATP Binding Cassette Subfamily B Member 1) • ABCG2 (ATP Binding Cassette Subfamily G Member 2) • IL13 (Interleukin 13) • IL4 (Interleukin 4) • SLCO2B1 (Solute Carrier Organic Anion Transporter Family Member 2B1)
|
rifampicin
15d
Molecular and immune landscape of recurrent and/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC/IMMUCAN project. (PubMed, Clin Cancer Res)
Our study highlights key molecular and immune differences across R/M SCCHN subgroups, identifies potential biomarkers, and suggests biological rationales for tailored therapeutic strategies.
Journal
|
PBRM1 (Polybromo 1) • IL6 (Interleukin 6) • CXCL12 (C-X-C Motif Chemokine Ligand 12) • FOXP1 (Forkhead Box P1) • DDR2 (Discoidin domain receptor 2) • IL13 (Interleukin 13) • IL15 (Interleukin 15) • ROBO2 (Roundabout Guidance Receptor 2)
21d
New trial
|
IL13 (Interleukin 13) • IL4 (Interleukin 4) • IL5 (Interleukin 5)
22d
Inflammatory exacerbation of hepatic alveolar echinococcosis during dupilumab therapy: A case report. (PubMed, IDCases)
Although causality cannot be established, inhibition of type 2 immune pathways may be associated with atypical inflammatory manifestations of latent helminth infections. Clinicians should remain vigilant for inflammatory presentations when prescribing biologic agents, particularly in endemic regions.
Journal
|
IL13 (Interleukin 13) • IL4 (Interleukin 4)
|
Dupixent (dupilumab)
24d
Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort. (PubMed, Wellcome Open Res)
In this South African cohort, HIV exposure-specific associations were observed between certain mother and child immune markers and child neurometabolite ratios at 2-3 years. Larger, longitudinal neuroimaging studies integrating neurodevelopmental outcomes are needed to clarify mechanisms and clinical implications.
Journal
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • MMP9 (Matrix metallopeptidase 9) • IL13 (Interleukin 13) • IL5 (Interleukin 5)
24d
MicroRNA-206-3p targeting heat shock protein 90αA1 in neuroinflammation and mitochondrial dysfunction in a rat model of heat stroke (PubMed, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue)
miR-206-3p participates in heat stroke-induced central nervous system injury through targeting HSP90αA1, which inhibits promotes apoptosis, and impairs mitochondrial function.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • IL17A (Interleukin 17A) • GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) • IL13 (Interleukin 13) • IL1B (Interleukin 1, beta) • MIR206 (MicroRNA 206) • HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1Heat Shock Protein 90 Alpha Family Class A Member 1)
28d
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis (clinicaltrials.gov)
P2, N=403, Recruiting, Innovent Biologics (Suzhou) Co. Ltd. | Not yet recruiting --> Recruiting
Enrollment open
|
IL13 (Interleukin 13)
|
Dupixent (dupilumab)